Back to Boston Trust Walden Corp Boston Trust Walden Corp

ACLSACLS
8 quarters

Position history for Boston Trust Walden CorpBoston Trust Walden Corp's holdings in Axcelis Technologies Inc

Boston Trust Walden Corp holds 359,256 shares of ACLS (Axcelis Technologies Inc), worth $68.1M as of 2026-Q2. The position was decreased (-5.1% shares). ACLS represents 0.5% of Boston Trust Walden Corp's portfolio.

Current Value

$68.1M

Current Shares

359,256

Total Value Change

+$15M

Total Shares Change

-147,171

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
359,256
-5.1%
$68.1M0.5%$189.45
0
2026-Q1
Decreased
378,525
-11.5%
$35.2M0.3%$93.08
0
2025-Q4
Decreased
427,736
-7.1%
$34.4M0.3%$80.34
0
2025-Q3
Decreased
460,287
-45.6%
$44.9M0.3%$97.64
0
2025-Q2
Increased
845,911
+2.4%
$59M0.4%$69.69
36
2025-Q1
Increased
826,332
+0.8%
$41M0.3%$49.67
35
2024-Q4
Increased
820,116
+61.9%
$57.3M0.4%$69.87
51
2024-Q3
New
506,427
-
$53.1M0.4%$104.85
49

Other major holders of ACLS: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used